Search by name:
A B C D E F G H I J K L M N O P R S T U V W X Y Z
Diabetes
  • Glucophage
    $0.23
    Glucophage is an oral diabetes medicine used to treat type 2 of diabetes.
  • Glucotrol
    $0.23
    Glucotrol is sulfonylurea class of drugs, a drug used to treat type 2 of diabetes.
  • Actos
    $0.33
    Actos (Pioglitazone) is used to control high blood sugar in type 2 diabetes (non-insulin-dependent diabetes ...
  • DDAVP
    $3.43
    Generic DDAVP is used to prevent or control the frequent urination and loss of water caused by diabetes ...
  • Glucophage SR
    $0.61
    Glucophage SR is an oral diabetes medicine used to treat type 2 of diabetes.
  • Prandin
    $0.72
    Prandin is used to stimulate insulin secretion from the pancreas in treatment of type 2 of diabetes mellitus.
  • Precose
    $0.73
    Acarbose slows the digestion of carbohydrates in the body, which helps control blood sugar levels.
  • Amaryl
    $0.54
    Amaryl is an oral blood sugar-lowering drug which belongs to the class of sulfonylureas.
  • Glucotrol Xl
    $0.27
    Glucotrol Xl is sulfonylurea class of drugs, a drug used to treat type 2 of diabetes.
  • Glucovance
    $0.61
    Glucovance is a combination of two orally taken drugs possessing a hyproglycemic effect. Used to treat ...
  • Glycomet
    $0.88
    Glycomet is an oral diabetes medicine used to treat type 2 of diabetes.
  • Micronase
    $0.37
    Micronase contains glyburide, which lowers glucose levels in the blood.
  • Starlix
    $0.67
    Starlix (nateglinide) is an oral diabetes medicine that helps control blood sugar levels.
Payment Methods
Secure Payment Process
News
Music 'calms nerves before surgery' as well as sedative
The "world's most relaxing song" could be just as good at calming patients' nerves, a study suggests.
Plant-based milks on the rise: A quarter of Britons are drinking them
Whether it's almond, soy or coconut it seems cow's milk is being ditched for alternatives.
NHS boss: Tax bills could mean 'loss of 60 doctors'
Doctors' refusal to work overtime is the issue, its chief executive warns.